Contract facts
NONEPS-2 DROGUE RELEASE MODIFICATION is a federal NONE award for Commander held by Airborne Systems North America of Nj Inc. Estimated value —. Related solicitation M6785425R1001.
Incumbent footprint
Public recordAirborne Systems North America of Nj Inc — $37.2M obligated across 62 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract M6785425D1001?
M6785425D1001 (Ps-2 DROGUE release modification) is a Commander award with an estimated value of —, currently held by Airborne Systems North America of Nj Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is M67854-25-D-1001?
M67854-25-D-1001 is the dashed form of PIID M6785425D1001 (Ps-2 DROGUE release modification), held by Airborne Systems North America of Nj Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded M6785425D1001?
Commander awarded M6785425D1001 to Airborne Systems North America of Nj Inc.
Who is the incumbent on M6785425D1001?
Airborne Systems North America of Nj Inc is the incumbent with $37.2M across 62 related awards in SCOUT’s public footprint.
When does Airborne Systems North America of Nj Inc’s M6785425D1001 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.